Array Biopharma Inc (NASDAQ:ARRY)

During the Trading Day
7.81 +0.69 / +9.77%
Data as of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
7.92 +0.115 / +1.47%
Volume: 9.1K
Health Technology

Company Description

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Its proprietary drug development pipeline is primarily focused on the treatment of cancer and inflammatory disease and includes clinical candidates that are designed to regulate therapeutically important targets. The company also discovers and develops drug candidates across a broad range of therapeutic areas in collaboration with leading pharmaceutical and biotechnology companies such as AstraZeneca, Novartis, InterMune and Roche. Array BioPharma was founded by Kevin Koch, Anthony Piscopio, K.C. Nicolaou and David L. Snitman in 1998 and is headquartered in Boulder, CO.

Contact Information

Array BioPharma, Inc.
3200 Walnut Street
Boulder Colorado 80301
P:(303) 381-6600
Investor Relations:
(303) 386-1193



Other institutional61.85%
Mutual fund holders32.08%
Individual stakeholders15.06%

Top Executives

Ron SquarerChief Executive Officer & Director
David L. SnitmanChief Operating Officer & VP-Business Development
R. Michael CarruthersChief Financial Officer & Head-Investor Relations
Nick A. SaccomanoChief Scientific Officer
Robert E. WinklerVice President-Clinical Research & Development

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.